EUVIMEDEUVIMED entdecken
Open Access

VASN Enhances IGF2BP3 Stability via USP10 Deubiquitination to Promote Triple-negative Breast Cancer Paclitaxel Resistance

Hao Liu, Zexiu Lu, Maoshan Chen, Zhenghang Li, Jian Chen, Xingyu Yang, Xueying Wan, Gang Tu, Manran Liu, Lingfeng Tang

International Journal of Biological Sciences · 13.07.2026 · 22 (12) · 6583-6607

DOI: 10.7150/ijbs.136403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 13.07.2026. Verfasst von Hao Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing …. Hauptthemen laut MEDLINE: Paclitaxel, Triple Negative Breast Neoplasms, Ubiquitin Thiolesterase, Drug Resistance, Neoplasm. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelTriple Negative Breast NeoplasmsUbiquitin ThiolesteraseDrug Resistance, NeoplasmRNA-Binding ProteinsMicrofilament ProteinsHumansFemaleAnimalsMiceCell Line, TumorUbiquitinationMDA-MB-231 CellsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ABCB1VASNchemoresistancetriple-negative breast cancer

Substanzen

PaclitaxelUbiquitin ThiolesteraseRNA-Binding ProteinsUSP10 protein, humanMicrofilament Proteins

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
  • Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of education, Chongqing Medical University, Chongqing 400016, China.

Zitieren

APA

Liu, H., Lu, Z., Chen, M., Li, Z., Chen, J., Yang, X., Wan, X., Tu, G., Liu, M., & Tang, L. (2026). VASN Enhances IGF2BP3 Stability via USP10 Deubiquitination to Promote Triple-negative Breast Cancer Paclitaxel Resistance. International Journal of Biological Sciences, 22(12), 6583-6607. https://doi.org/10.7150/ijbs.136403

Vancouver

Liu H, Lu Z, Chen M, Li Z, Chen J, Yang X, et al. VASN Enhances IGF2BP3 Stability via USP10 Deubiquitination to Promote Triple-negative Breast Cancer Paclitaxel Resistance. International Journal of Biological Sciences. 2026;22(12):6583-6607. doi:10.7150/ijbs.136403

BibTeX
@article{Liu2026,
  author = {Liu, Hao and Lu, Zexiu and Chen, Maoshan and Li, Zhenghang and Chen, Jian and Yang, Xingyu and Wan, Xueying and Tu, Gang and Liu, Manran and Tang, Lingfeng},
  title = {VASN Enhances IGF2BP3 Stability via USP10 Deubiquitination to Promote Triple-negative Breast Cancer Paclitaxel Resistance},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {12},
  pages = {6583--6607},
  doi = {10.7150/ijbs.136403}
}
Kostenlos starten →